Virtus Silvant Small/Mid Growth ETF (SSMG)

On our growth desk, we are monitoring SSMG's recent April 2026 inception. While the concept of targeting small- and mid-cap disruptors through Silvant Capital Management is appealing, the current assets under management sitting right around $3.28M to $3.39M make it a tough allocation for institutional scale without moving the market ourselves.

Looking at the liquidity metrics reported for SSMG, the 20-day average trading volume is roughly 140 shares, with a 1-month average volume around 166 shares. For a risk manager, these ultra-low figures present a severe structural liquidity risk, regardless of how attractive the underlying fundamental thesis on secular growth trends might be.

In our clinical market reviews, we note that the fund relies heavily on portfolio managers Michael A. Sansoterra and Dr. Sandeep Bhatia to pick winners from the Russell 2500 Growth Index universe. Their qualitative screening for disruptive products needs to quickly translate into inflows to overcome the drag of a 0.39% total expense ratio on such a tiny asset base.

From a quantitative perspective, the 30-day median bid/ask spread of 0.39% combined with a 4 PM bid/offer midpoint near $26.22 signals that execution costs will eat into alpha quickly. Until creation/redemption activity picks up and assets scale past the micro-cap threshold, retail or tactical entry must be handled via limit orders only.

Our options and trading desk flags the lack of listed options liquidity on SSMG right now. Since the fund is newly traded on NYSE Arca with limited float and a share count hovering around 125,004 shares, traditional hedging strategies via derivatives are practically non-existent.